Faculty profile

Michael Farkouh

ResearcherMedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Michael Farkouh

Researcher

Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Principal investigator on 7 research grants (7 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Clinical Trials Adaptive Trials Biostatistics Hqp Development Job Shadowing Mentorship Pedogagy Training

Latest papers

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.
The New England journal of medicine · 2026
A comparison of computational algorithms for the Bayesian analysis of clinical trials.
Clinical trials (London, England) · 2024
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.
The pharmacogenomics journal · 2024

All 29 publications

Latest funding

Canadian Cardiovascular Research Collaboratory (C3) General Meeting
CIHR · 2023 · Co-investigator
$15,000
Efficacy of antioxidant therapy in mild to moderate SARS-CoV-2 infection: An experimental arm of the CanTreatCOVID adaptive platform trial
CIHR · 2023 · Co-investigator
$100,000
Bariatric surgery for the Reduction of cArdioVascular Events randomized controlled (BRAVE) trial: vanguard phase for assessment of feasibility
CIHR · 2023 · Co-investigator
$531,064

All 26 grants and awards

29 publications.

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.

Lok CE, Farkouh M, Hemmelgarn BR, Moist LM, Polkinghorne KR, Tomlinson G, Tam P, Tonelli M, Udell JA, PISCES Investigators

The New England journal of medicine2026

DOI: 10.1056/nejmoa2513032 PMID: 41201837

A comparison of computational algorithms for the Bayesian analysis of clinical trials.

Chen Z, Berger JS, Castellucci LA, Farkouh M, Goligher EC, Hade EM, Hunt BJ, Kornblith LZ, Lawler PR, Leifer ES, Lorenzi E, Neal MD, Zarychanski R, Heath A

Clinical trials (London, England)2024

DOI: 10.1177/17407745241247334 PMID: 38752434

Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.

Huxley S, Moriarty J, Hlatky MA, Lennon R, Bailey K, Bell M, Geller N, Lerman A, Mathew V, Rosenberg Y, Farkouh M, Rihal C, Borah B, Pereira NL

The pharmacogenomics journal2024

DOI: 10.1038/s41397-024-00353-y PMID: 39379363

Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.

Redfors B, Stone GW, Alexander JH, Bates ER, Bhatt DL, Biondi-Zoccai G, Caldonazo T, Farkouh M, Rahouma M, Puskas J, Sandner S, Gaudino MFL

Journal of the American College of Cardiology2024

DOI: 10.1016/j.jacc.2023.11.002 PMID: 37956961

Adherence to clinical practice guidelines for pulmonary valve intervention after tetralogy of Fallot repair: A nationwide cohort study.

Massarella D, McCrindle BW, Runeckles K, Fan S, Dahdah N, Dallaire F, Drolet C, Grewal J, Hancock-Friesen CL, Hickey E, Karur GR, Khairy P, Leonardi B, Keir M, Nadeem SN, Ng MY, Shah A, Tham EB, Therrien J, Warren AE, Vonder Muhll IF, Van de Bruane A, Yamamura K, Farkouh M, Wald RM

JTCVS open2024

DOI: 10.1016/j.xjon.2023.11.013 PMID: 38420530

Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.

Hosseini F, Franco C, Whalen BA, Taylor CM, Sellers SL, Khan N, Kaila K, Bainey K, Farkouh M, Gupta M, Verma S, Ramanathan K

The Canadian journal of cardiology2023

DOI: 10.1016/j.cjca.2023.07.028 PMID: 37517476

Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.

Smilowitz NR, Hade EM, Kornblith LZ, Castellucci LA, Cushman M, Farkouh M, Gong MN, Heath A, Hunt BJ, Kim KS, Kindzelski A, Lawler P, Leaf DE, Goligher E, Leifer ES, McVerry BJ, Reynolds HR, Zarychanski R, Hochman JS, Neal MD, Berger JS

Research and practice in thrombosis and haemostasis2023

DOI: 10.1016/j.rpth.2023.102167 PMID: 37727846

Automated digital counselling with social network support as a novel intervention for patients with heart failure: protocol for randomised controlled trial.

Peiris RG, Ross H, Chan CT, Poon S, Auguste BL, Rac VE, Farkouh M, McDonald M, Kaczorowski J, Code J, Duero Posada J, Ong S, Kobulnik J, Tomlinson G, Huszti E, Arcand J, Thomas SG, Akbari A, Maunder R, Grover S, Seto E, Simard A, Pope B, Bains M, McIntyre C, Torbay C, Syed F, Nolan RP

BMJ open2022

DOI: 10.1136/bmjopen-2021-059635 PMID: 36691152

Historical Neighborhood Redlining and Contemporary Cardiometabolic Risk.

Motairek I, Lee EK, Janus S, Farkouh M, Freedman D, Wright J, Nasir K, Rajagopalan S, Al-Kindi S

Journal of the American College of Cardiology2022

DOI: 10.1016/j.jacc.2022.05.010 PMID: 35798451

Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study.

Avram R, So D, Iturriaga E, Byrne J, Lennon R, Murthy V, Geller N, Goodman S, Rihal C, Rosenberg Y, Bailey K, Farkouh M, Bell M, Cagin C, Chavez I, El-Hajjar M, Ginete W, Lerman A, Levisay J, Marzo K, Nazif T, Olgin J, Pereira N

JMIR formative research2022

DOI: 10.2196/34080 PMID: 35699977

Canadian Cardiovascular Research Collaboratory (C3) General Meeting

Co-investigatorCIHR2023Planning and Dissemination Grant - Institute Community Support

Principal investigators: Goodman, Shaun G

Keywords: Cardiovascular Disease

$15,000

Efficacy of antioxidant therapy in mild to moderate SARS-CoV-2 infection: An experimental arm of the CanTreatCOVID adaptive platform trial

Co-investigatorCIHR2023Project Grant - PA: Pandemic Preparedness and Health Emergencies Research

Principal investigators: Hosseini, Benita; Jenkins, David J; Pinto, Andrew D

Keywords: Adaptive Platform Randomized Trial; Antioxidant Therapy; Clinical Symptoms; Cost Effectiveness; Covid-19; Multi-Center Study; Treatment Efficacy

$100,000

Bariatric surgery for the Reduction of cArdioVascular Events randomized controlled (BRAVE) trial: vanguard phase for assessment of feasibility

Co-investigatorCIHR2023Project Grant

Principal investigators: Yusuf, Salim; Wong, Jorge A

Keywords: Bariatric Surgery; Efficacy And Safety Trial; Individuals With High-Risk Cvd And Severe Obesity; Multicentre And Multinational Study; Randomized Controlled Trial

$531,064

CLEAR-HORIZONS Post-Sepsis Platform Trial: Statin Pilot RCT

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Lawler, Patrick R

Keywords: Atorvastatin; Long-Term Outcomes; Pandemic Preparedness; Pilot; Post-Infection Syndrome; Randomized Controlled Trial; Sepsis

$112,231

CLEAR-HORIZONS Post-Sepsis Platform Trial: Statin Pilot RCT

Co-investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Lawler, Patrick R

Keywords: Atorvastatin; Long-Term Outcomes; Pandemic Preparedness; Pilot; Post-Infection Syndrome; Randomized Controlled Trial; Sepsis

$448,925

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms

Principal investigators: Cheung, Angela M; Ahmed, Sofia B; Allen, Upton D; Bhat, Mamatha; Boyd, Steven K; Crawley, Angela M; Dolatabadi, Elham; Fahim, Christine; Farkouh, Michael E; Feld, Jordan J; Fox, Susan; Furlan, Andrea D; Goligher, Ewan C; Hodgson, David C; Inman, Robert D; Juando Prats, Clara; Lamontagne, Francois; Langlois, Marc-Andre; Levin, Adeera; Mansfield, Avril; Manske, Sarah L; McMaster, W. Robert; Mylopoulos, Maria; Oza, Amit M; Papaioannou, Alexandra; Pinto, Andrew D; Quinn, Kieran L; Rahman, Proton; Razak, Fahad; Richard, Nicolas; Richardson, Harriet; Sander, Beate H; Sellmann, Susanna; Stelfox, Henry T; Straus, Sharon E; Tartaglia, Maria Carmela; Tobe, Sheldon W; Tomlinson, George A; Verma, Amol; Walmsley, Sharon L; Wu, Robert; Xu, Wei

Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training

$4,314,242

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)

Co-investigatorCIHR2022Project Grant

Principal investigators: Zarychanski, Ryan; Lawler, Patrick R; Turgeon, Alexis F

Keywords: Community Acquired Pneumonia; Heparin; Randomized Trial; Therapeutic Anticoagulation

$3,961,936

Canadian Training Platform for Trials Leveraging Existing Networks (CAN-TAP-TALENT)

Principal investigatorCIHR2022Training Grant: Clinical Trials Training Platforms - Indirect Costs

Keywords: Adaptive Trials; Biostatistics; Clinical Trials; Hqp Development; Job Shadowing; Mentorship; Pedogagy; Training

$1,078,562

Secondary Prevention Community Heart Outcomes Improvement and Cholesterol Education Study (Secondary CHOICES)

Co-investigatorCIHR2021Project Grant - Priority Announcement: Health Services and Policy Research

Principal investigators: Udell, Jacob A

Keywords: Audit And Feedback; Health Equity; Secondary Prevention Of Cardiovascular Disease

$100,000

The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy (STICH 3.0) Trial

Co-investigatorCIHR2021Project Grant

Principal investigators: Fremes, Stephen E; Gaudino, Mario; Jolicoeur, Marc E; Rouleau, Jean-Lucien

Keywords: Coronary Artery Bypass Grafting; Coronary Artery Disease; Health Economics; Heart Failure; Ischemic Cardiomyopathy; Major Adverse Cardiac And Cerebral Events; Mortality; Percutaneous Coronary Intervention; Quality Of Life

$2,786,128

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Michael Farkouh

Research

Latest papers

Latest funding

Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis.

A comparison of computational algorithms for the Bayesian analysis of clinical trials.

Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.

Outcomes According to Coronary Revascularization Modality in the&#xa0;ISCHEMIA Trial.

Adherence to clinical practice guidelines for pulmonary valve intervention after tetralogy of Fallot repair: A nationwide cohort study.

Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.

Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial.

Automated digital counselling with social network support as a novel intervention for patients with heart failure: protocol for randomised controlled trial.

Historical Neighborhood Redlining and Contemporary Cardiometabolic Risk.

Patient Onboarding and Engagement to Build a Digital Study After Enrollment in a Clinical Trial (TAILOR-PCI Digital Study): Intervention Study.

Frequent collaborators

Anna Heath

George Tomlinson

Brian Wong

Amer Johri

Paaladinesh Thavendiranathan

Derek So

Heather Ross

Ryan Zarychanski

Noah Ivers

Patrick Lawler

Kevin Bainey

Ayub Akbari

Paul Oh

Shaun Goodman

Ayodele Odutayo

Anna Heath

Scott Thomas

Jacob Udell

Paul Yip

JoAnne Arcand

Ewan Goligher

Paul Khairy

Emily Seto

Steven Grover

Marcello Tonelli

Jack Goodman

Robert Maunder

Keyvan Karkouti

Nadia Khan

Stephanie Ong

Kim Connelly

Noah Ivers

Neeraj Narula

Subodh Verma

John Kenneth Marshall

Janusz Kaczorowski

Gunther Eysenbach

Outcomes According to Coronary Revascularization Modality in the ISCHEMIA Trial.